Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection

Annapaola Callegaro, Daniela Borleri, Claudio Farina, Gavino Napolitano, Daniela Valenti, Marco Rizzi, Franco Maggiolo
doi: https://doi.org/10.1101/2021.03.09.21253203

Article Information

doi 
https://doi.org/10.1101/2021.03.09.21253203
History 
  • March 11, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Annapaola Callegaro1,2,
  2. Daniela Borleri3,
  3. Claudio Farina1,
  4. Gavino Napolitano1,2,
  5. Daniela Valenti4,5,
  6. Marco Rizzi5 and
  7. Franco Maggiolo5
  1. 1Microbiology and Virology Laboratory ASST Papa Giovanni XXIII, Bergamo, Italy
  2. 2Biobank ASST Papa Giovanni XXIII, Bergamo, Italy
  3. 3Occupational Medicine Unit ASST Papa Giovanni XXIII, Bergamo, Italy
  4. 4,5FROM Foundation ASST Papa Giovanni XXIII, Bergamo, Italy
  5. 5Division of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy
  1. * Corresponding author; email: ap.callegaro{at}gmail.com
Back to top
Posted March 11, 2021.
Download PDF
Data/Code
Email
Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection
Annapaola Callegaro, Daniela Borleri, Claudio Farina, Gavino Napolitano, Daniela Valenti, Marco Rizzi, Franco Maggiolo
medRxiv 2021.03.09.21253203; doi: https://doi.org/10.1101/2021.03.09.21253203
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area